Probi AB
Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children's, women's, and senior health, as well as iron absorption. It provides dietary … Read more
Probi AB (PROB) - Total Assets
Latest total assets as of September 2024: Skr1.52 Billion SEK
Based on the latest financial reports, Probi AB (PROB) holds total assets worth Skr1.52 Billion SEK as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Probi AB - Total Assets Trend (2000–2023)
This chart illustrates how Probi AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Probi AB - Asset Composition Analysis
Current Asset Composition (December 2023)
Probi AB's total assets of Skr1.52 Billion consist of 36.3% current assets and 63.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 22.1% |
| Accounts Receivable | Skr94.02 Million | 6.3% |
| Inventory | Skr116.70 Million | 7.8% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr340.27 Million | 22.8% |
| Goodwill | Skr340.58 Million | 22.9% |
Asset Composition Trend (2000–2023)
This chart illustrates how Probi AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Probi AB's current assets represent 36.3% of total assets in 2023, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 22.1% of total assets in 2023, down from 69.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, an increase from 11.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 22.9% of total assets.
Probi AB Competitors by Total Assets
Key competitors of Probi AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Probi AB - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Probi AB generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Probi AB generates $ 1.13 in net profit.
Probi AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.27 | 6.58 | 4.40 |
| Quick Ratio | 4.83 | 5.05 | 3.48 |
| Cash Ratio | 0.00 | 3.51 | 0.00 |
| Working Capital | Skr471.97 Million | Skr 478.65 Million | Skr 292.41 Million |
Probi AB - Advanced Valuation Insights
This section examines the relationship between Probi AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.90 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -5.1% |
| Total Assets | Skr1.49 Billion |
| Market Capitalization | $106.63 Million USD |
Valuation Analysis
Below Book Valuation: The market values Probi AB's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Probi AB's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Probi AB (2000–2023)
The table below shows the annual total assets of Probi AB from 2000 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | Skr1.49 Billion | -5.06% |
| 2022-12-31 | Skr1.57 Billion | +9.62% |
| 2021-12-31 | Skr1.43 Billion | +15.51% |
| 2020-12-31 | Skr1.24 Billion | -3.86% |
| 2019-12-31 | Skr1.29 Billion | +6.63% |
| 2018-12-31 | Skr1.21 Billion | +8.89% |
| 2017-12-31 | Skr1.11 Billion | -8.30% |
| 2016-12-31 | Skr1.21 Billion | +431.50% |
| 2015-12-31 | Skr227.88 Million | +29.49% |
| 2014-12-31 | Skr175.99 Million | +17.55% |
| 2013-12-31 | Skr149.72 Million | +9.50% |
| 2012-12-31 | Skr136.73 Million | +5.64% |
| 2011-12-31 | Skr129.43 Million | -4.21% |
| 2010-12-31 | Skr135.12 Million | +11.39% |
| 2009-12-31 | Skr121.30 Million | +8.75% |
| 2008-12-31 | Skr111.54 Million | +7.56% |
| 2007-12-31 | Skr103.70 Million | +25.91% |
| 2006-12-31 | Skr82.36 Million | -0.70% |
| 2005-12-31 | Skr82.94 Million | -10.88% |
| 2004-12-31 | Skr93.07 Million | +28.85% |
| 2003-12-31 | Skr72.23 Million | -4.10% |
| 2002-12-31 | Skr75.32 Million | -31.77% |
| 2001-12-31 | Skr110.39 Million | -0.96% |
| 2000-12-31 | Skr111.46 Million | -- |